Person

Michel Vounatsos

Director, Revvity

Current S&P 500 boards
1
Current roles
1
Open-market buys
$2.8M
Open-market sales
$0

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

  • BIIB
    Biogen
    DirectorChief Executive Officer
    Apr 2016 – last filing Feb 2022

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Nov 30, 2020BIIBBuy3,100$241.31$748K
May 1, 2019BIIBBuy4,351$231.48$1.0M
Dec 29, 2017BIIBBuy780$320.55$250K
May 1, 2017BIIBBuy1,402$271.35$380K
Feb 27, 2017BIIBBuy1,333$285.39$380K

SEC reporting-owner ID (CIK) 1672709 · all filings on EDGAR